NEWS

Recently, Shandong INTCO Medical Products Co., Ltd. has been awarded the honorary title of “Qingzhou Innovative Enterprise” under its excellent innovative practice and innovative culture with the full participation of all staff.

As a global leading high-tech manufacturer of medical consumables and devices, INTCO Medical has always regarded innovation as the core driving force for the development of the enterprise. In 2023, the company's R&D investment amounted to 283 million yuan and continued to increase technological research. Through the introduction of a potentiometric titrator, rotational viscometer, grinder, desktop spectrophotometer, and other internationally advanced experimental equipment, the company has realized the technological upgrading of the whole process from raw material testing to the finished product process. These hard-core inputs have significantly improved the stability of product performance and provided a solid guarantee for the quality breakthrough of core products such as nitrile gloves and PVC gloves.

Talent is the wing of the whole staff innovation to activate the endogenous power

Understanding that “talent is the first resource of innovation”, INTCO Medical has built a high-level R&D team by combining attraction and nurturing. By the end of 2023, the company's R&D personnel had reached 972, accounting for 8.89% of the total number of employees, forming a composite talent matrix covering materials science, process engineering, intelligent manufacturing, and other fields. Special training is conducted regularly, covering cutting-edge topics such as production process optimization and precision instrument operation, achieving 100% full coverage of R&D personnel. This training mode of “knowledge sharing + combat practice” has enabled the team to successfully break through several “choke point” technologies and declare 269 patents.

Culture-based improvement of innovation empowers industrial upgrading

In INTCO Medical, “full innovation” is not a slogan. The company encourages every employee to participate in improvement and innovation by establishing an improvement and innovation proposal system and an improvement and innovation reward fund. The “cooling tank waste heat recovery transformation program” proposed by the production workshop staff has greatly reduced the use of coal; the “antibacterial gloves” developed by the R&D team, with an antibacterial rate of more than 90%, have pushed the products into the high-end market. This mode of “top-down strategic leadership, bottom-up staff co-creation” makes innovation truly integrated into the corporate DNA.

From the technological breakthroughs in the laboratory to the process innovation in the production line, from the R&D elites to the wisdom of the frontline staff, INTCO Medical is writing a new chapter on the high-quality development of China's health protection industry with the pen of innovation. Under the guidance of the “Healthy China 2030” strategy, INTCO Medical will continue to use the power of science and technology to build a strong global health defense.